Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
Stroke Trial Links
Government Sites
Independent Sites
News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback
Search for Trials
PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Repinotan
Bay x 3702

Action
Serotonin agonist (5HT1A receptor subtype)

Status
Phase II trial completed. Phase III stroke trial (RECT) ongoing as of 1/01. Trials in traumatic brain injury also ongoing.

Trial(s)
  = Ongoing
  = Completed

BRAINS Repinotan in Acute Ischemic Stroke
RECT Repinotan - Randomized Exposure Controlled Trial

Web Links and Publications
Bayer Web Site.
Repinotan (BAY x 3702): A 5HT1A agonist in traumatically brain injured patients.
J Neurotrauma. 2001 Dec;18(12):1313-21.
BAY X 3702.
Drugs R D 1999 Jan;1(1):16-7

UID: 7

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2010 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, March 12, 2010